Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | June 16, 2023 01:32pm

Gainers

  • Oncorus (NASDAQ:ONCR) shares moved upwards by 144.6% to $0.19 during Friday's regular session. Trading volume for Oncorus's stock is 170.4 million as of 13:31 EST. This is 12952.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.9 million.
  • Evelo Biosciences (NASDAQ:EVLO) stock increased by 119.66% to $0.18. As of 13:31 EST, Evelo Biosciences's stock is trading at a volume of 122.3 million, which is 2749.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.3 million.
  • SCWorx (NASDAQ:WORX) stock moved upwards by 58.45% to $0.6. Trading volume for this security as of 13:31 EST is 59.9 million, which is 4062.0% of its average full-day volume over the last 100 days. The company's market cap stands at $7.7 million.
  • Navidea Biopharmaceutical (AMEX:NAVB) stock increased by 30.36% to $0.11. The current volume of 78.1 million shares is 3507.3% of Navidea Biopharmaceutical's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $3.7 million.
  • Sientra (NASDAQ:SIEN) shares moved upwards by 22.59% to $2.17. Trading volume for this security as of 13:31 EST is 629.5K, which is 67.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.2 million.
  • Mallinckrodt (AMEX:MNK) shares rose 21.9% to $1.06. Trading volume for this security as of 13:31 EST is 2.2 million, which is 151.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.9 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) shares decreased by 38.6% to $0.51 during Friday's regular session. As of 13:31 EST, this security is trading at a volume of 1.7 million shares, making up 3474.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.0 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) stock fell 32.79% to $0.62. Trading volume for this security as of 13:31 EST is 18.7 million, which is 544.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.1 million.
  • Coherus BioSciences (NASDAQ:CHRS) shares decreased by 23.29% to $4.13. As of 13:31 EST, Coherus BioSciences's stock is trading at a volume of 10.1 million, which is 478.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $389.0 million.
  • Stereotaxis (AMEX:STXS) stock fell 19.33% to $1.63. The current volume of 1.5 million shares is 574.5% of Stereotaxis's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $131.4 million.
  • Olema Pharmaceuticals (NASDAQ:OLMA) shares fell 15.48% to $7.67. As of 13:31 EST, Olema Pharmaceuticals's stock is trading at a volume of 327.0K, which is 141.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $312.8 million.
  • Vaccinex (NASDAQ:VCNX) stock decreased by 13.64% to $0.38. Vaccinex's stock is trading at a volume of 242.8K shares as of 13:31 EST. This is 169.7% of its average full-day volume over the last 100 days. The company's market cap stands at $24.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CHRS EVLO MNK NAVB OLMA ONCR SIEN SONN STXS UPC VCNX WORX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist